Harmony Biosciences Holdings (HRMY) Non Operating Income (2019 - 2023)

Harmony Biosciences Holdings (HRMY) has 5 years of Non Operating Income data on file, last reported at -$2.9 million in Q3 2023.

• For the quarter ending Q3 2023, Non Operating Income rose 27.17% year-over-year to -$2.9 million; the trailing twelve-month figure through Sep 2023 stood at -$11.9 million (up 26.81% YoY), and the FY2022 full-year result was -$15.7 million, up 34.63% from the prior year.
• Non Operating Income retreated to -$2.9 million in Q3 2023, from -$2.8 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of -$2.1 million in Q3 2019 to a low of -$8.0 million in Q4 2020.
• A 5-year average of -$4.8 million and a median of -$4.2 million in 2022 frame the typical range for Non Operating Income.
• Across the five-year window, Non Operating Income sank 231.55% in 2020 and jumped 47.44% in 2021, its largest moves.
• Tracing HRMY's Non Operating Income over 5 years: stood at -$2.7 million in 2019, then sank by 189.99% to -$8.0 million in 2020, then jumped by 47.44% to -$4.2 million in 2021, then increased by 14.43% to -$3.6 million in 2022, then climbed by 18.89% to -$2.9 million in 2023.
• Business Quant data shows HRMY's Non Operating Income at -$2.9 million in Q3 2023, -$2.8 million in Q2 2023, and -$2.6 million in Q1 2023.